Evidence map›Paper›PMID 38736705›Full record

ArticleBiologics : targets & therapy2024

Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula.

Sota Katsube, Satohiro Matsumoto, Masahiro Misawa, Nao Kakizawa, Ryo Hashimoto, Taku Mizutani, Keita Matsumoto, Shuhei Yoshikawa, Hirosato Mashima

Abstract readCase Reports
In one paragraph

Article in Biologics : targets & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sota KatsubeDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0009-0009-0056-044X
Satohiro MatsumotoDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0001-7802-3980
Masahiro MisawaDepartment of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Nao KakizawaDepartment of General and Gastrointestinal Surgery, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Ryo HashimotoDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Taku MizutaniDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Keita MatsumotoDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Shuhei YoshikawaDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Hirosato MashimaDepartment of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.ORCID 0000-0001-8448-9576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The patient was a 50-year-old Japanese woman who was diagnosed with total-colitis-type ulcerative colitis (UC) at the age of 26 years. She was treated with mesalazine and azathioprine, and her disease activity was well controlled. At the age of 50 years, the patient was experiencing fever, abdominal pain, diarrhea, bloody stool, and anal pain, which led to a diagnosis of a relapse of UC. Although steroid therapy was administered and tended to improve her symptoms, fecaloid vaginal discharge occurred, and rectovaginal fistula (RVF) was confirmed. Colostomy was performed, and infliximab was initiated as maintenance therapy for UC. All symptoms improved, and RVF closure was confirmed 6 months after the initiation of infliximab. To date, she has been free from relapse of UC. There have been only a few reports of UC complicated by RVF, and this condition is often difficult to treat. To the best of our knowledge, no other case of UC complicated by RVF in which the fistula was closed after treatment with colostomy and infliximab has been previously reported; thus, our report of the present case is valuable to the literature.

Indexed as

colostomyinfliximabrectovaginal fistulaulcerative colitis

Identifiers

PMID38736705
PMCPMC11086393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.